Omeros (OMER) Capital Expenditures (2010 - 2025)
Omeros (OMER) reported Capital Expenditures of $11000.0 for Q3 2025, up 1000.0% on a YoY basis from $1000.0 in Q3 2024, and down 15.38% sequentially from $13000.0 in Q2 2025.
Omeros (OMER) Capital Expenditures (2010 - 2025) Analysis & Trends
Omeros (OMER) has 16 years of Capital Expenditures data on file, last reported at $11000.0 in Q3 2025.
- For the quarter ending Q3 2025, Capital Expenditures rose 1000.0% year-over-year to $11000.0; the trailing twelve-month figure through Mar 2026 stood at $24000.0 (down 83.78% YoY), and the FY2025 full-year result was $65000.0, down 60.61% from the prior year.
- Capital Expenditures declined to $11000.0 in Q3 2025, from $13000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $275000.0 in Q2 2023 to a low of -$3000.0 in Q3 2022.
- A 5-year average of $58937.5 and a median of $37000.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 102.91% in 2022 and soared 1200.0% in 2023, its largest moves.
- Tracing OMER's Capital Expenditures over 5 years: stood at $74000.0 in 2021, then sank by 82.43% to $13000.0 in 2022, then soared by 807.69% to $118000.0 in 2023, then sank by 77.97% to $26000.0 in 2024, then plunged by 57.69% to $11000.0 in 2025.
- Business Quant data shows OMER's Capital Expenditures at $11000.0 in Q3 2025, $13000.0 in Q2 2025, and $41000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 275,000.00 |
| Jun 30, 2023 | 275,000.00 |